Interestingly, Pan et al. [83] demonstrated that loss of IPMK impairs autophagy activation in osteosarcoma cells when treated with Ebastine, a second-generation antihistaminic drug effective in inhibiting osteosarcoma cell proliferation. The gene discussed is IPMK; the disease is osteosarcoma.